Tonix Pharmaceuticals Holding Stock In The News

TNXP Stock  USD 27.71  0.59  2.18%   
Our overall analysis of Tonix Pharmaceuticals' news coverage and content from conventional and social sources shows investors' bearish mood towards Tonix Pharmaceuticals Holding. The specific impact of Tonix Pharmaceuticals news on its stock price will depend on a range of factors, including the nature and significance of the news report and investors' perceptions of Tonix Pharmaceuticals' overall financial health and prospects. It also depends on the type and quality of a news publisher. Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using Tonix Pharmaceuticals headlines in addition to utilizing other, more conventional financial analysis modules. Check out Tonix Pharmaceuticals Backtesting and Tonix Pharmaceuticals Hype Analysis.

Tonix Pharmaceuticals Today Top News and Investor Outlook

Macroaxis News: globenewswire.com
Tonix Pharmaceuticals Announces Positive Pre-IND Meeting with FDA for TNX-102 SL for the Treatment of Major Depressive Disorder
https://www.globenewswire.com/news-release/2025/09/18/3152335/28908/en/Tonix-Pharmaceuticals-Announces-Positive-Pre-IND-Meeting-with-FDA-for-TNX-102-SL-for-the-Treatment-of-Major-Depressive-Disorder.html
 Bearish
nasdaq News
Tonix In-Licenses TNX-4800 For Seasonal Lyme Disease Prevention
https://www.nasdaq.com/articles/tonix-licenses-tnx-4800-seasonal-lyme-disease-prevention
 Neutral
Macroaxis News: globenewswire.com
Tonix Pharmaceuticals Announces In-licensing Phase 2/3-Ready Monoclonal Antibody Designed for Seasonal Prevention of Lyme Disease (TNX-4800)
https://www.globenewswire.com/news-release/2025/09/17/3151488/28908/en/Tonix-Pharmaceuticals-Announces-In-licensing-Phase-2-3-Ready-Monoclonal-Antibody-Designed-for-Seasonal-Prevention-of-Lyme-Disease-TNX-4800.html
 Neutral
seekingalpha News
Mpox in Africa is no longer a global health emergency, WHO chief says
https://seekingalpha.com/news/4492876-mpox-in-africa-longer-health-emergency-who-says?utm_source=feed_news_all&utm_medium=referral&feed_item_type=news
 Neutral
seekingalpha News
SA analyst upgrades/downgrades: HD, AAPL, TMUS, TNXP
https://seekingalpha.com/news/4487565-sa-analyst-upgradesdowngrades-hd-aapl-tmus-tnxp?utm_source=feed_news_all&utm_medium=referral&feed_item_type=news
 Bullish
news
What's going on in today's session
https://www.chartmill.com/news/TNXP/Chartmill-33336-Whats-going-on-in-todays-session
 Bullish
Investing News at Macroaxis
UnitedHealth, Duolingo Lead Market Cap Stock Movers on Monday
https://www.investing.com/news/stock-market-news/unitedhealth-duolingo-lead-market-cap-stock-movers-on-monday-93CH-4198320
 Neutral
news
Monday's session: top gainers and losers
https://www.chartmill.com/news/TNXP/Chartmill-33330-Mondays-session-top-gainers-and-losers
 Bullish
seekingalpha News
Tonix drops 20% despite winning approval for fibromyalgia drug
https://seekingalpha.com/news/4486611-tonix-drops-20-despite-winning-approval-fibromyalgia-drug?utm_source=feed_news_all&utm_medium=referral&feed_item_type=news
 Bullish
news
Let's uncover which stocks are experiencing notable gaps during today's session.
https://www.chartmill.com/news/TNXP/Chartmill-33328-Lets-uncover-which-stocks-are-experiencing-notable-gaps-during-todays-session
 Bullish

Tonix Pharmaceuticals Holding Past News Timeline

Popular news outlets such as MarketWatch, Bloomberg, or Reuters provide Tonix and other traded companies coverage with news coverage. We help investors stay connected with Tonix headlines for the 18th of September 2025 to make an informed investment decision based on correlating the impacts of news items on Tonix Stock performance. Please note that trading solely based on the Tonix Pharmaceuticals Holding hype is not for everyone as timely availability and quick action are needed to avoid losses.
Tonix Pharmaceuticals' linear event process diagram shows some of the filtered current and past headlines as well as many other corporate-specific events such as SEC filings, dividends, and regulatory reporting available to the public. This module can help Tonix Pharmaceuticals Holding investors visualize upcoming and past events in order to time the market based on Tonix Pharmaceuticals Holding noise-free hype analysis.

Tonix Pharmaceuticals Investors Sentiment

The influence of Tonix Pharmaceuticals' investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Tonix. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock market does not have solid backing from leading economists and market statisticians.
Investor biases related to Tonix Pharmaceuticals' public news can be used to forecast risks associated with an investment in Tonix. The trend in average sentiment can be used to explain how an investor holding Tonix can time the market purely based on public headlines and social activities around Tonix Pharmaceuticals Holding. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Tonix Pharmaceuticals' market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Tonix Pharmaceuticals' and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average Tonix Pharmaceuticals' news discussions. The higher the estimated score, the more favorable is the investor's outlook on Tonix Pharmaceuticals.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Tonix Pharmaceuticals in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Tonix Pharmaceuticals' short interest history, or implied volatility extrapolated from Tonix Pharmaceuticals options trading.

Additional Tools for Tonix Stock Analysis

When running Tonix Pharmaceuticals' price analysis, check to measure Tonix Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Tonix Pharmaceuticals is operating at the current time. Most of Tonix Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Tonix Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Tonix Pharmaceuticals' price. Additionally, you may evaluate how the addition of Tonix Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.